MetGen Oy is an innovative biotech SME who designs, develops, supplies and markets novel enzymatic solutions and technologies around them for the most challenging of industrial conditions to meet our customer-specific needs. MetGen was found in 2008 and is based in Kaarina, Finland. The company is currently backed by some of the leading venture capital investors and industrial partners. MetGen is a member of the Bio-based Industries Consortium and a consortium member to 11 EU Horizon2020 projects ranging from R&D efforts to Flagship factories.
MetGen uses advances in genetic engineering and microbiology to adapt enzymes to harsh industrial conditions and to handle a variety of lignocellulosic substrates to fulfill the company’s mission: Empower industries to maximize the value out of biomass.
MetGen’s enzyme products – MetZymes® – are industrial, highly-active, natural catalysts that accelerate chemical reactions. They can survive in harsh industrial environments which enables novel applications and disruptive new technologies, such as METNIN™ for lignin valorization. The products and technologies are protected by international patents.
MetGen has created a disruptive technology platform, ENZINE®, to develop industrial enzymes at a world-leading speed and unparalleled efficiency. The company has achieved industrial successes with sector leaders in forest and renewable chemicals. The team aspires to be a widely recognized and preferred supplier of industrial enzymes, significantly contributing to the economics and sustainability of process industries such as pulp & paper, biofuels, and biochemicals.
MetGen is readily prepared to address the full value-chain in bioprocessing – from feedstock to consumer goods and valorization of side streams – with its MetZyme® product portfolio.
